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Summary
2-Ketoisocaproate (KIC), the last intermediate in
L-leucine biosynthesis, has various medical and
industrial applications. After deletion of the ilvE gene
for transaminase B in L-leucine production strains of
Corynebacterium glutamicum, KIC became the major
product, however, the strains were auxotrophic for
L-isoleucine. To avoid auxotrophy, reduction of IlvE
activity by exchanging the ATG start codon of ilvE by
GTG was tested instead of an ilvE deletion. The result-
ing strains were indeed able to grow in glucose
minimal medium without amino acid supplementa-
tion, but at the cost of lowered growth rates and KIC
production parameters. The best production perfor-
mance was obtained with strain MV-KICF1, which
carried besides the ilvE start codon exchange three
copies of a gene for a feedback-resistant 2-
isopropylmalate synthase, one copy of a gene for a
feedback-resistant acetohydroxyacid synthase and
deletions of ltbR and iolR encoding transcriptional
regulators. In the presence of 1 mM L-isoleucine,
MV-KICF1 accumulated 47 mM KIC (6.1 g l−1) with a
yield of 0.20 mol/mol glucose and a volumetric prod-
uctivity of 1.41 mmol KIC l−1 h−1. Since MV-KICF1 is
plasmid free and lacks heterologous genes, it is an
interesting strain for industrial application and as
platform for the production of KIC-derived com-
pounds, such as 3-methyl-1-butanol.
Introduction
Corynebacterium glutamicum is the major host for
biotechnological production of amino acids, the most
important ones being the flavor enhancer L-glutamate
and the feed additive L-lysine. In the past decades,
C. glutamicum strains have been developed for the pro-
duction of various other commercially interesting com-
pounds (Becker and Wittmann, 2012), including organic
acids (Okino et al., 2008; Litsanov et al., 2012a,b;
Wieschalka et al., 2013), diamines (Mimitsuka et al.,
2007; Kind and Wittmann, 2011; Schneider and
Wendisch, 2011) or alcohols (Inui et al., 2004; Smith
et al., 2010; Blombach et al., 2011). Besides small mol-
ecules, also heterologous proteins can be efficiently pro-
duced with this Gram-positive bacterium (Scheele et al.,
2013, and references therein). Thus, C. glutamicum has
become a production platform in white biotechnology.
Three monographs (Eggeling and Bott, 2005; Burkovski,
2008; Yukawa and Inui, 2013) document the rapidly
increasing knowledge on this species, which is based on
the genome sequence (Ikeda and Nakagawa, 2003;
Kalinowski et al., 2003) and efficient techniques for its
genetic engineering (Kirchner and Tauch, 2003).
The spectrum of amino acids produced with
C. glutamicum includes the essential branched-chain
amino acids (BCAAs) L-valine, L-isoleucine and L-leucine,
which are produced in quantities of up to 5000 tons per
year in a steadily growing market (Becker and Wittmann,
2012). They have different applications in the food, feed
and pharmaceutical industry (Park and Lee, 2010). The
biosynthesis pathways of the BCAAs in C. glutamicum are
overlapping and partly share the same precursors and
enzymes (Fig. 1). The direct precursors of L-valine,
L-isoleucine and L-leucine are 2-ketoisovalerate (KIV),
2-keto-3-methylvalerate (KMV), and 2-ketoisocaproate
(KIC) respectively. These keto acids are predominantly
transaminated to the respective amino acids by the
transaminase IlvE (Radmacher et al., 2002; Marienhagen
et al., 2005). Similar to their corresponding amino acids,
KIV, KMV and KIC have a variety of applications in the
medical, biological and food area, since they play an
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important role in living organisms as regulatory factors
in metabolism and key intermediates in biosynthesis
(Krause et al., 2010; Zhu et al., 2011; Bückle-Vallant
et al., 2014). They are used, for example, in the therapy of
chronic kidney disease patients (Aparicio et al., 2012).
Similar to L-leucine, KIC has anti-catabolic properties
through inhibition of muscle proteolysis and provokes
enhancement of protein synthesis, especially in the skel-
etal muscle (Escobar et al., 2010; Zanchi et al., 2011).
Additionally, an insulin-releasing action of KIC (Heissig
et al., 2005) and an inhibitory effect on glucagon release
(Leclercq-Meyer et al., 1979) were discussed. It has been
shown that KIC can also serve as a basis for the produc-
tion of the biofuel isopentanol (Cann and Liao, 2010).
Fig. 1. Biosynthesis pathways and their control by various regulatory mechanisms of the three branched-chain amino acids and the respective
keto acids in C. glutamicum. Enzymes and their corresponding genes are shown in boxes. Lines with ‘+’ indicate activation of gene expres-
sion; ‘-’ indicates repression of gene expression (solid lines) or transcription attenuation or feedback inhibition (dashed lines). ‘Leu’, ‘Val’ and
‘Ile’ indicate the presence of L-leucine, L-valine and L-isoleucine respectively. Not shown is the avtA gene encoding the branched-chain amino
acid transaminase AvtA, which predominantly transaminates 2-ketoisovalerate to L-valine. Abbreviations: AHAIR, acetohydroxyacid
isomeroreductase; AHAS, acetohydroxyacid synthase; BCAA-E, branched-chain amino acid exporter (BrnFE); BCAA-T, branched-chain amino
acid transaminase IlvE; DHAD, dihydroxyacid dehydratase; IPMD, 3-isopropylmalate dehydratase; IPMDH, 3-isopropylmalate dehydrogenase;
IPMS, 2-isopropylmalate synthase; Lrp, leucine-responsive regulatory protein; LtbR, leucine and tryptophane biosynthesis regulator; TD,
threonine dehydratase (threonine ammonia-lyase).
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KIV, KMV and KIC are mainly produced by chemical
synthesis using harsh reaction conditions and multiple
purification steps resulting in plenty of waste (Cooper
et al., 1983). The biotechnological production of these
keto acids is thus an interesting alternative. Besides a
biotransformation process with Rhodococcus opacus
using L-leucine as substrate for KIC formation (Zhu et al.,
2011), fermentative processes with glucose as substrate
have recently been described for the production of KIV
(Krause et al., 2010) and KIC (Bückle-Vallant et al., 2014),
showing that deletion of ilvE in certain engineered
C. glutamicum strains results in KIC formation. Whereas
these strains contained plasmids and in part heterologous
genes, the C. glutamicum KIC production strains devel-
oped in our work are plasmid free and lack heterologous
genes.
Results and discussion
Initial studies on KIC production using
plasmid-containing strains of C. glutamicum
Based on recently developed efficient production strains
of C. glutamicum ATCC 13032 (Abe et al., 1967) for
L-leucine (Vogt et al., 2014), we intended to modify these
strains for the production of KIC. The conversion of KIC to
L-leucine is catalysed by the transaminase IlvE, which
also converts KIV to L-valine and KMV to L-isoleucine
using L-glutamate as amino donor (Radmacher et al.,
2002; Marienhagen et al., 2005). An ilvE deletion has
been reported to cause auxotrophy for L-leucine and
L-isoleucine, but not for L-valine, since the transaminase
AvtA also effectively converts KIV to L-valine using
L-alanine as amino donor (Marienhagen et al., 2005).
According to this knowledge, deletion of ilvE in L-leucine
production strains should lead to the accumulation
of KIC and potentially also KMV. In a first series of
experiments, we deleted ilvE in the wild-type
C. glutamicum ATCC 13032 and transformed the ΔilvE
mutant with plasmid pAN6-leuA_B018, carrying an IPTG-
inducible leuA allele encoding a feedback-resistant
2-isopropylmalate synthase (IPMS) (Vogt et al., 2014).
2-Isopropylmalate synthase of C. glutamicum is strongly
inhibited by L-leucine with a Ki of 0.4 mM (Pátek et al.,
1994) and the presence of a feedback-resistant variant is
the key for L-leucine overproduction (Vogt et al., 2014).
The ΔilvE mutant and the ΔilvE strain with plasmid pAN6-
leuA_B018 were cultivated in 500 ml baffled Erlenmeyer
flasks with 50 ml CGXII minimal medium (Keilhauer et al.,
1993) with 4% (w/v) glucose, 1 mM L-leucine and 1 mM
L-isoleucine at 30°C and 120 rpm on a rotary shaker.
Keto acids and amino acids were quantified by high-
performance liquid chromatography as described (Vogt
et al., 2014). Chromosomal in-frame deletions and
integrations of DNA fragments were performed by two-
step homologous recombination using the vector
pK19mobsacB (Schäfer et al., 1994) and a method
described previously (Niebisch and Bott, 2001).
Corynebacterium glutamicum ΔilvE exhibited a growth
rate of 0.38 ± 0.01 h−1 and excreted up to 5 mM KIV but
no detectable concentrations of KIC (detection limit
< 0.1 mM), whereas C. glutamicum ΔilvE pAN6-
leuA_B018 showed a growth rate of 0.30 ± 0.01 h−1 and
accumulated 37 ± 0.7 mM KIC in the supernatant
when induced with 0.1 mM IPTG, confirming that over-
expression of the leuA allele encoding the feedback-
resistant IPMS increased metabolic flux into the leucine
pathway (Fig. 1). Surprisingly, C. glutamicum ΔilvE carry-
ing pAN6-leuA_B018 also accumulated L-leucine (12.3 ±
0.4 mM) and in fact was only auxotrophic for L-isoleucine,
but not for L-leucine. A possible limitation of L-valine due to
a high metabolic flux from KIV towards KIC was excluded
for this strain since additional supplementation of L-valine
did not improve growth (data not shown). Accumulation of
L-leucine was also reported for other KIC-producing ΔilvE
strains and explained by the activity of unspecific
transaminases (e.g. AlaT or AvtA) using KIC as substrate
when it is present in high concentrations (Bückle-Vallant
et al., 2014). Consequently, supplementation of the
medium with L-leucine was omitted in the following culti-
vations. The formation of L-leucine as by-product addi-
tionally necessitates the presence of feedback-resistant
IPMS for KIC overproduction. The results described
above demonstrated that our previously described
L-leucine producers (Vogt et al., 2014) can serve as basis
for the construction of KIC production strains.
Deletion of ilvE in plasmid-free L-leucine
production strains
Analogous to our strategy used for L-leucine strain devel-
opment (Vogt et al., 2014), we intended to construct KIC
production strains devoid of plasmids, heterologous genes
and auxotrophies. Depending on the composition of the
medium used in the fermentation process, auxotrophies
can necessitate the addition of supplements, increasing
the costs of the fermentation process. Plasmids usually
necessitate the addition of antibiotics to the medium, which
is undesirable for production strains applied in the food and
feed industry and can be prohibited by regulatory author-
ities (Tauch et al., 2002). Moreover, the absence of
plasmids, antibiotic resistance markers and heterologous
genes often results in more stable producer strains (Pátek,
2007). The use of heterologous genes is also an undesired
trait for strains used in the food and feed industry. In a first
attempt to construct a plasmid-free KIC producer, we
deleted the ilvE gene in the previously constructed
L-leucine producer MV-Leu20 (Table 1; Vogt et al., 2014),
which contains a deletion of the ltbR gene, encoding a
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repressor of the L-leucine biosynthesis genes, and a
replacement of the wild-type leuA gene by the feedback-
resistant variant leuA_B018 under control of the strong tuf
promoter (Vogt et al., 2014). In shake flask cultivations with
CGXII medium containing 4% (w/v) glucose, MV-Leu20
accumulated about 20 mM L-leucine. When cultivated in
the same medium supplemented with 1 mM L-isoleucine,
the strain MV-Leu20 ΔilvE accumulated 18.0 ± 1.6 mM KIC
in the supernatant and formed as by-products 5.6 ±
0.3 mM L-leucine, 2.1 ± 0.5 mM KIV and 7.3 ± 1.7 mM
KMV. Since KIV and KMV are substrates of the tran-
saminase IlvE (Marienhagen et al., 2005), the ilvE deletion
leads to an accumulation of these keto acids. The presum-
ably low concentrations of L-isoleucine and L-valine in
strain MV-Leu20 ΔilvE may also contribute to overproduc-
tion of KIV and KMV by reducing the feedback-inhibition of
threonine dehydratase (encoded by ilvA) by L-isoleucine
(Möckel et al., 1992) and of acetohydroxyacid synthase
(encoded by ilvBN) by L-valine and L-isoleucine (Eggeling
et al., 1987).
As mentioned above, L-leucine formation in the
absence of the transaminase IlvE is presumably due to
Table 1. Strains and plasmids used in this studya,b.
Strain or plasmid Relevant characteristicsc Source or reference
C. glutamicum strains
Wild type ATCC 13032, biotin-auxotrophic Abe and colleagues (1967)
ΔilvE ATCC 13032 derivative with in-frame deletion of ilvE Marienhagen and
colleagues (2005)
MV-Leu20 Rationally designed C. glutamicum L-leucine producer (ΔltbR
ΔleuA::Ptuf-leuA_B018)
Vogt and colleagues (2014)
MV-Leu20 ΔilvE MV-Leu20 derivative with in-frame deletion of ilvE This study
SH-KIC20 MV-Leu20 derivative with chromosomal replacement of ATG start codon of ilvE by
GTG start codon
This study
MV-LeuF1 Rationally designed C. glutamicum L-leucine producer (ΔltbR::Ptuf-leuA_B018
ΔleuA::Ptuf-leuA_B018 IR(cg1121/1122)::Ptuf-leuA_B018 ΔiolR ilvN_fbr)
Vogt and colleagues (2014)
MV-KICF1 MV-LeuF1 derivative with chromosomal replacement of ATG start codon of ilvE by
GTG start codon
This study
ΔilvE Δcg0018 ΔilvE derivative with cg0018 in-frame deletion This study
ΔilvE Δcg1121 ΔilvE derivative with cg1121 in-frame deletion This study
ΔilvE Δcg1219 ΔilvE derivative with cg1219 in-frame deletion This study
ΔilvE Δcg1419 ΔilvE derivative with cg1419 in-frame deletion This study
ΔilvE Δcg1658 ΔilvE derivative with cg1658 in-frame deletion This study
ΔilvE Δcg2557 ΔilvE derivative with cg2557 in-frame deletion This study
ΔilvE Δcg2676 ΔilvE derivative with cg2676 in-frame deletion This study
ΔilvE Δcg3334 ΔilvE derivative with cg3334 in-frame deletion This study
ΔilvE Δcg1121::cg1121 ΔilvE Δcg1121 derivative with re-integrated gene cg1121 into its wild-type locus This study
E. coli strains
DH5α F− Φ80lacZΔM15 Δ(lacZYA-argF)U169 recA1 endA1 hsdR17 (rK−, mK+) phoA
supE44 λ– thi-1 gyrA96 relA1
Invitrogen (Karlsruhe,
Germany)
Plasmids
pAN6 Kanr; E. coli/C. glutamicum shuttle vector for inducible gene expression (Ptac,
lacI q, pBL1 pUC18 oriVE.coli, pBL1 oriVC.glutamicum)
Frunzke and colleagues
(2008)
pAN6-leuA_B018 Kanr; pAN6 derivative containing leuA allele coding for feedback-resistant
2-isopropylmalate synthase under control of the tac promoter
Vogt and colleagues (2014)
pAN6-leuA_B018-cg1121 Kanr; pAN6-leuA_B018 derivative carrying additional gene coding for cg1121
along with its upstream (94 bp) and downstream (305 bp) regions
This study
pK19mobsacB Kanr; vector for allelic exchange in C. glutamicum (pK18 oriVE.coli sacB lacZα) Schäfer and colleagues
(1994)
pK19mobsacB-ΔilvE Kanr, pK19mobsacB derivative for in-frame deletion of gene ilvE Marienhagen and
colleagues (2005)
pK19mobsacB-GTG-ilvE Kanr, pK19mobsacB derivative for replacement of ATG start codon of ilvE by GTG This study
pK19mobsacB-Δcg0018 Kanr, pK19mobsacB derivative for in-frame deletion of gene coding for Cg0018 This study
pK19mobsacB-Δcg1121 Kanr, pK19mobsacB derivative for in-frame deletion of gene coding for Cg1121 This study
pK19mobsacB-Δcg1219 Kanr, pK19mobsacB derivative for in-frame deletion of gene coding for Cg1219 This study
pK19mobsacB-Δcg1419 Kanr, pK19mobsacB derivative for in-frame deletion of gene coding for Cg1419 This study
pK19mobsacB-Δcg1658 Kanr, pK19mobsacB derivative for in-frame deletion of gene coding for Cg1658 This study
pK19mobsacB-Δcg2557 Kanr, pK19mobsacB derivative for in-frame deletion of gene coding for Cg2557 This study
pK19mobsacB-Δcg2676 Kanr, pK19mobsacB derivative for in-frame deletion of gene coding for Cg2676 This study
pK19mobsacB-Δcg3334 Kanr, pK19mobsacB derivative for in-frame deletion of gene coding for Cg3334 This study
pK19mobsacB-cg1121 Kanr, pK19mobsacB derivative for re-integration of gene coding for Cg1121 into
its wild-type locus
This study
a. All constructed plasmids as well as chromosomal deletions and integrations in engineered strains were verified by DNA sequencing.
b. Plasmid constructions were performed in E. coli DH5α. Description of plasmid constructions and used DNA oligonucleotides (Table S1) can be
found in the Supporting Information.
c. Kanr, kanamycin resistance
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high cytoplasmic KIC concentrations, allowing its conver-
sion by other transaminases such as AvtA that have weak
affinities for KIC (Marienhagen et al., 2005). To test this
assumption, we measured the cytoplasmic KIC concen-
trations in the wild type and strain MV-Leu20 ΔilvE. Cells
were grown in CGXII medium with 4% (w/v) glucose,
harvested in the early exponential phase (optical density
at 600 nm (OD600 = 5), and cytoplasmic concentrations
were determined as described (Paczia et al., 2012). The
internal KIC concentration of the wild type was below the
detection limit of 5 μM, whereas MV-Leu20 ΔilvE accumu-
lated approximately 2.8 mM KIC inside the cell, corre-
sponding to a more than 500-fold increase.
Exchange of the ilvE start codon in plasmid-free
L-leucine production strains
To avoid the L-isoleucine auxotrophy of strain MV-Leu20
ΔilvE, we intended to reduce IlvE activity to a value that
was high enough to provide L-isoleucine for growth, but
low enough to allow KIC overproduction. For this purpose,
the ATG start codon of ilvE was exchanged against GTG,
which should decrease the translation rate (Becker et al.,
2010) of the ilvE transcript and thereby reduce the specific
IlvE activity. The start codon exchange was performed in
the L-leucine producers MV-Leu20 and MV-LeuF1
(Table 1). The latter strain contains (i) three copies of the
leuA_B018 gene in the chromosome under control of the
tuf promoter, two of them replacing ltbR and the native
leuA gene, (ii) a deletion of iolR (Klaffl et al., 2013) for
enhanced glucose uptake and (iii) a feedback-resistant
acetohydroxyacid synthase encoded by ilvN_fbr (Vogt
et al., 2014). The strains SH-KIC20 (from MV-Leu20) and
MV-KICF1 (from MV-LeuF1) resulting from the ilvE start
codon exchange (Table 1) were cultivated in CGXII
medium with 4% (w/v) glucose to test for KIC accumula-
tion in the supernatant (Fig. 2).
Without supplementation of L-isoleucine, SH-KIC20
showed a strongly reduced growth rate of 0.08 ± 0.01 h−1
compared with the ancestor strain MV-Leu20 (0.31 ±
0.01 h−1). This phenotype suggests that the ilvE start
codon exchange reduced the availability of BCAAs and
consequently the growth rate. Strain SH-KIC20 accumu-
lated about 19 mM KIC in 49 h, which correlates with the
KIC concentration produced by MV-Leu20 ΔilvE. The
slower growth of SH-KIC20 led to a lowered volumetric
productivity of 0.38 mmol l−1 h−1 in comparison to
MV-Leu20 ΔilvE (approximately 0.8 mmol l−1 h−1). Strain
MV-KICF1 showed a growth rate of only 0.03 ± 0.01 h−1,
which is 85% lower than the one of the parent strain
(μ = 0.20 ± 0.01 h−1), and yielded a maximal KIC con-
centration of 33 mM after 95 h (Table 2). Supplementa-
tion of the medium with 1 mM L-isoleucine enabled
MV-KICF1 to reach the same growth rate (μ = 0.21 ±
0.01 h−1) as its parent MV-LeuF1 and to form 47 ±q
4 mM KIC (6.1 g l−1) after 32 h with a yield of
0.20 ± 0.02 mol KIC per mol of glucose and a pro-
ductivity of 1.41 ± 0.13 mmol KIC l−1 h−1 (Table 2). Both
SH-KIC20 and MV-KICF1 formed KIV, KMV and
L-leucine as by-products (Table 2).
The results described above demonstrate that the start
codon exchange for reduction of IlvE activity was suc-
cessful and allowed growth and KIC accumulation
without supplementation of BCAAs; however, the produc-
tion parameters were lower compared with supplemen-
tation with 1 mM L-isoleucine (Table 2). A successful
industrial application depends on high product yields
combined with sufficient cell growth, resulting in
Fig. 2. Growth and KIC formation of different C. glutamicum strains
in shake flasks with CGXII minimal medium containing 4% (w/v)
glucose.
A. MV-Leu20 without supplements (growth, ■; KIC, □), MV-Leu20
ΔilvE supplemented with 1 mM L-isoleucine (growth, ●; KIC, ○)
and SH-KIC20 without supplements (growth, ▲; KIC, △).
B. MV-LeuF1 without supplements (growth, ▼; KIC, ▽), MV-KICF1
without supplements (growth, ◀; KIC, ◁) and MV-KICF1 with 1 mM
L-isoleucine (growth, ◆; KIC, ◇). The data represent mean
values and standard deviations obtained from three independent
cultivations.
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competitive productivity. Therefore, the addition of
L-isoleucine is still important to improve growth of the
constructed strains to reach better productivity values. As
an alternative approach to adjust the IlvE activity to an
optimal value for prototrophic growth with simultaneous
KIC production, ilvE gene expression could be fine-tuned
by testing promoters with varying strength (Vašicová
et al., 1999; Hammer et al., 2006).
Recently, Bückle-Vallant and colleagues (2014)
described a plasmid-based C. glutamicum strain for the
production of KIC. This strain is characterized by deletions
of the genes ilvE, ltbR, prpC1 and prpC2, an exchange of
the two gltA promoters (van Ooyen et al., 2011) by the
mutated dapA promoter L1 (Vašicová et al., 1999) to
reduce citrate synthase activity (van Ooyen et al., 2012),
and plasmid-based overexpression of ilvBNCD and a leuA
allele of Escherichia coli encoding a feedback-resistant
IPMS. This strain accumulated up to 71 mM KIC when
cultivated with glucose plus acetate as carbon sources
and supplemented with 2 mM each of L-isoleucine and
L-valine. Under cultivation conditions comparable to ours,
i.e. without acetate, this strain reached KIC titres
(54 ± 4 mM) and yields (0.22 mol per mol of glucose) in a
similar range as strain MV-KICF1 when supplemented with
L-isoleucine. In comparison, the biotransformation with
Rhodococcus opacus transcribed by Zhu and colleagues
(2011) reached about 10 mM KIC using 39 mM L-leucine
as substrate.
2-Ketoisocaproate transport
When MV-KICF1 was batch cultivated in a bioreactor as
described (Vogt et al., 2014) using a medium sup-
plemented with 1 mM L-isoleucine, comparable KIC titres
as in shake flasks of about 50 mM were achieved (data
not shown). Interestingly, additional feeding of glucose in
fed-batch experiments did not further increase the KIC
concentrations and led to an arrest of cell growth and
glucose consumption (data not shown). A possible expla-
nation is a block of the L-leucine biosynthesis pathway by
elevated KIC concentrations, as Bückle-Vallant and
colleagues (2014) found competitive inhibition of IPMS by
KIC and non-competitive inhibition of 3-isopropylmalate
dehydratase by KIC. Additionally, a competitive inhibition
Table 2. Growth and production parameters of strains MV-KICF1 and SH-KIC20 in shake flask cultivationsa,b.
Parameter
MV-KICF1 + 1 mM
L-isoleucine
MV-KICF1 without
L-isoleucine
SH-KIC20d without
L-isoleucine
Growth rate (h−1) 0.21 ± 0.01 0.03 ± 0.01 0.08 ± 0.01
KIC (mM) 46.7 ± 4.1 31.8 ± 2.1 18.8 ± 0.67
By-productsc:
KIV (mM) 13.3 ± 2.2 19.0 ± 4.1 2.6 ± 0.3
KMV (mM) 8.8 ± 1.3 4.9 ± 0.6 8.7 ± 0.1
L-leucine (mM) 3.0 ± 0.2 10.3 ± 3.1 4.8 ± 0.2
Molar product yield (mol KIC per mol glucose) 0.204 ± 0.018 0.143 ± 0.010 0.084 ± 0.001
Volumetric productivity (mmol KIC l−1 h−1) 1.41 ± 0.13 0.34 ± 0.02 0.38 ± 0.02
a. Cultivations were performed in 500 ml baffled shake flasks containing 50 ml CGXII minimal medium with 4% (w/v) glucose. Supplementation
of L-isoleucine is indicated.
b. Mean values and standard deviations from three independent cultivations are shown.
c. Concentrations of L-valine and L-isoleucine were below 2 mM.
d. Cultivation of SH-KIC20 supplemented with 1 mM L-isoleucine was not tested.
Table 3. Putative transporter genes showing increased expression in a KIC producer.
Gene Annotation
mRNA ratioa (MV-Leu20
ΔilvE/ Wild type TMHb
cg0018 putative membrane protein, conserved 3.5 9
cg1121 putative permease of the major facilitator superfamily 2.2 7
cg1219 putative membrane protein 3.5 10
cg1419 putative Na+-dependent transporter, bile acid:Na+ symporter BASS family 7.2 8
cg1658 putative permease of the major facilitator superfamily 35.6 12
cg2557 putative secondary Na+/bile acid symporter, bile acid:Na+ symporter BASS family 2.5 8
cg2676 putative ABC-type dipeptide/oligopeptide/nickel transport system, permease component 2.1 6
cg3334 putative arabinose efflux permease, MFS type 2.0 12
a. Transcriptome analyses of KIC producer MV-Leu20 ΔilvE in comparison to the wild type were performed using DNA microarrays as described
(Vogt et al., 2014). Candidate transporter genes were chosen based on an mRNA ratio (MV-Leu20 ΔilvE/wild type) of > 2, an annotation as
(putative) membrane or transporter proteins and the prediction of multiple transmembrane helices in the encoded proteins. Data represent mean
values of at least two (maximum four) evaluable microarray experiments (P-value < 0.05).
b. TMH, number of transmembrane helices predicted with the SOSUI engine version 1.11.
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of acetohydroxyacid synthase by KIV has been reported
by Krause and colleagues (2010). To avoid a reduced flux
into the leucine synthesis pathway by competitive inhibi-
tion of IPMS by KIC, the concentration of KIV within the
cell needs to be increased and/or the concentration of KIC
within the cell should be decreased. These concentrations
are determined on one hand by the rates of synthesis and
further metabolic conversion and on the other hand by the
rates of export to and import from the supernatant.
Knowledge on KIC transport is very limited. Obviously,
as shown by our studies and that of Bückle-Vallant and
colleagues (2014), KIC can leave the cell, and previous
studies by Groeger and Sahm (1987) demonstrated that
KIC can enter the cell. As previously described for
L-isoleucine (Zittrich and Krämer, 1994), passive diffusion,
carrier-mediated uptake and carrier-mediated excretion
must be considered as possibilities for an amphiphilic
solute like KIC to cross the cytoplasmic membrane. Due
to its similarity to L-isoleucine, it seems likely that also KIC
is able to diffuse across the membrane. However, a
necessity to possess carriers for KIC import or KIC export
is not obvious, in contrast to the advantage of having
importers for amino acids and exporters for non-
catabolizable amino acids. In C. glutamicum, the export of
BCAAs and methionine is catalysed by the exporter
BrnFE (Kennerknecht et al., 2002; Trötschel et al., 2005;
Xie et al., 2012), but evidence is available that BrnFE
is not involved in KIC export (Radespiel, 2010). The
identification of transporters can be beneficial for
biotechnological processes to increase productivity since
transport of desired products into the medium often rep-
resents a bottleneck. For example, export was identified
as a limiting factor for L-isoleucine production with C.
glutamicum (Morbach et al., 1996), and the production of
this BCAA was improved by overexpression of the respec-
tive transporter encoded by brnFE (Kennerknecht et al.,
2002; Xie et al., 2012).
In order to test if a KIC exporter is present in
C. glutamicum that might be useful to improve KIC over-
production, we searched for genes showing increased
mRNA levels during KIC production by performing com-
parative transcriptome analyses using DNA microarrays
as described previously (Vogt et al., 2014). KIC producer
strain MV-Leu20 ΔilvE was compared with the wild type
to determine differentially expressed genes, resulting
in a list of eight candidate transporter genes (Table 3).
Each of these genes was deleted in the C. glutamicum
ΔilvE background, and the resulting double deletion
mutants were transformed with pAN6-leuA_B018. When
cultivated in glucose minimal medium with 0.1 mM IPTG,
one of the eight strains, which contained a deletion of
cg1121 (annotated as putative permease of the major
facilitator superfamily), showed a reduced growth rate
(0.23 ± 0.01 h−1) and a reduced maximal KIC titre
Fig. 3. Complementation of the effects on growth and KIC accumu-
lation caused by deletion of cg1121 in strain C. glutamicum ΔilvE
carrying pAN6-leuA_B018.
A. Growth of strains ΔilvE with pAN6-leuA_B018 (■), ΔilvE
Δcg1121 with pAN6-leuA_B018 (●), ΔilvE Δcg1121::cg1121 with
pAN6-leuA_B018 (△) and ΔilvE Δcg1121 with pAN6-leuA_B018-
cg1121 (▽) are shown.
B. Maximal KIC concentrations reached after 32 h cultivation in
500 ml baffled shake flasks with 50 ml CGXII minimal medium con-
taining 4% (w/v) glucose and 0.1 mM IPTG at 30°C and 120 rpm
on a rotary shaker. The deletion of cg1121 was complemented
either by genomic reintegration of cg1121 (ΔilvE Δcg1121::cg1121
pAN6-leuA_B018) or by plasmid-borne expression of cg1121 (ΔilvE
Δcg1121 pAN6-leuA_B018-cg1121). The data represent mean
values and standard deviations obtained from three independent
cultivations.
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(22.4 mM) compared with the reference strain ΔilvE
pAN6-leuA_B018 (0.30 ± 0.01 h−1, 37 mM KIC). The
phenotype could be complemented by reintegration of
cg1121 into the genome of strain ΔilvE Δcg1121 or by
plasmid-borne expression of cg1121 (Fig. 3). However,
the specific KIC export rates (determined as described by
Kennerknecht et al., 2002) of strain ΔilvE Δcg1121
(6.5 ± 1.0 nmol min−1 gCDW−1) were not significantly
reduced compared with that of the reference strain ΔilvE
(8.0 ± 1.5 nmol min−1 gCDW−1) and the cytoplasmic KIC
concentrations of the two strains at an OD600 of 5
were comparable. Therefore, the role of Cg1121 for
growth and KIC production remains unclear and needs
further investigations.
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